These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16407047)

  • 21. Effect of acute acid loading on acid-base and calcium metabolism.
    Osther PJ
    Scand J Urol Nephrol; 2006; 40(1):35-44. PubMed ID: 16452054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of spontaneous crystalluria in patients with calcium oxalate calculi].
    Nguyen HV; Daudon M; Réveillaud RJ; Jungers P
    Nephrologie; 1987; 8(2):65-9. PubMed ID: 3614507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Plasma oxalate concentration in calcium oxalate stone formers].
    Hoshina A
    Hinyokika Kiyo; 1984 Oct; 30(10):1405-15. PubMed ID: 6524552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Saturation-inhibition index as a measure of the risk of calcium oxalate stone formation in the urinary tract.
    Robertson WG; Peacock M; Marshall RW; Marshall DH; Nordin BE
    N Engl J Med; 1976 Jan; 294(5):249-52. PubMed ID: 1244550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary macromolecules and renal tubular cell protection from oxalate injury: comparison of normal subjects and recurrent stone formers.
    Tsujihata M; Tsujikawa K; Tei N; Yoshimura K; Okuyama A
    Int J Urol; 2006 Mar; 13(3):197-201. PubMed ID: 16643608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new approach to calculate the risk of calcium oxalate crystallization from unprepared native urine.
    Laube N; Schneider A; Hesse A
    Urol Res; 2000 Aug; 28(4):274-80. PubMed ID: 11011968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients.
    Siener R; Schade N; Nicolay C; von Unruh GE; Hesse A
    J Urol; 2005 May; 173(5):1601-5. PubMed ID: 15821507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of freezer storage of urine samples on the BONN-Risk-Index for calcium oxalate crystallization.
    Laube N; Zimmermann DJ
    Clin Chem Lab Med; 2004; 42(6):665-9. PubMed ID: 15259384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Extended metabolic diagnosis of urolithiasis].
    Laube N; Bradenahl J; Thomas E; Meissner A; Müller SC
    Aktuelle Urol; 2006 Nov; 37(6):436-42; quiz 423-4. PubMed ID: 17099832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variability of the calcium ion activity with pH in stone-forming and non-stone-forming urine.
    Thode J; Holgersen RB; Gerstenberg T
    Scand J Clin Lab Invest Suppl; 1993; 214():121-6. PubMed ID: 8332846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Indicators of the risk of calcium oxalate urinary calculi: comparative study of the Parks' and Tiselius' indices, urinary citrate/calciuria ratio, and morning crystalluria].
    Robert M; Boularan AM; Guiter J; Monnier L
    Prog Urol; 1996 Apr; 6(2):264-8. PubMed ID: 8777421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones.
    Evan AP; Coe FL; Gillen D; Lingeman JE; Bledsoe S; Worcester EM
    Anat Rec (Hoboken); 2008 Mar; 291(3):325-34. PubMed ID: 18286613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary metabolic evaluation of stone formers-a Malaysian perspective.
    Hong YH; Dublin N; Razack AH; Mohd MA; Husain R
    Urology; 2012 Sep; 80(3):529-34. PubMed ID: 22578827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetics of calcium oxalate crystal formation in urine.
    Laube N; Klein F; Bernsmann F
    Urolithiasis; 2017 Apr; 45(2):151-157. PubMed ID: 27328814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intestinal oxalate absorption is higher in idiopathic calcium oxalate stone formers than in healthy controls: measurements with the [(13)C2]oxalate absorption test.
    Voss S; Hesse A; Zimmermann DJ; Sauerbruch T; von Unruh GE
    J Urol; 2006 May; 175(5):1711-5. PubMed ID: 16600737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystalline aggregation in vitro: interaction between urinary macromolecules and the micromolecular environment.
    Guerra A; Meschi T; Schianchi T; Allegri F; Novarini A; Borghi L
    Acta Biomed; 2002; 73(1-2):11-26. PubMed ID: 12233273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium oxalate stone formation risk - a case of disturbed relative concentrations of urinary components.
    Laube N; Rodgers A; Allie-Hamdulay S; Straub M
    Clin Chem Lab Med; 2008; 46(8):1134-9. PubMed ID: 18578688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A simple method for quantitating the propensity for calcium oxalate crystallization in urine.
    Wabner CL; Pak CY
    J Lithotr Stone Dis; 1991 Jul; 3(3):255-9. PubMed ID: 11536933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.